Newspaper Publication of Audited Financial Result for the quarter and year ended 31st March, 2026.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Genpharmasec Limited published its audited standalone and consolidated financial results for Q4 FY2026 and full year ended 31 March 2026 in newspapers on 23 May 2026, as required under SEBI Listing Regulations. The consolidated results show Total Income of Rs 5,644.49 lakhs for Q4 and Rs 14,309.47 lakhs for the full year. Net Profit after Tax was Rs 135.30 lakhs for Q4 and Rs 56.01 lakhs for the year. The company reported basic and diluted EPS of Rs 0.02 for Q4. The standalone results show Total Income of Rs 5,528.22 lakhs for Q4. Equity Share Capital stood at Rs 5,537.20 lakhs with Reserves of Rs 990.77 lakhs.
Routine regulatory filing publishing Q4 and annual audited financial results. The company has turned profitable in Q4 FY2026 after reporting losses in the previous quarter, which may be viewed positively by investors. No immediate impact expected on stock price as this is a compliance filing.